Status:
COMPLETED
Early Surgical Outcomes in the Use of Hybrid Mesh for Incisional Hernia Repair: Results From a Multicenter Italian Study
Lead Sponsor:
Azienda Sanitaria Locale Napoli 2 Nord
Conditions:
Hernia
Incisional Hernia
Eligibility:
All Genders
18+ years
Brief Summary
Background: Ventral hernia repair poses challenges for surgeons due to controversies in approach, patient selection, and mesh selection. The GORE® SYNECOR Intraperitoneal (IP) Biomaterial, a hybrid me...
Detailed Description
The management of ventral hernias, whether they are primary or incisional, presents a significant challenge for abdominal wall surgeons. Laparoscopic ventral hernia repair has become a widely accepted...
Eligibility Criteria
Inclusion
- age \> 18 years
- Clean wounds
- Informed consent
- Patients affected by Incisional and Ventral Hernia
- Elective surgery
- Hernia size between 3 e 10 cm
Exclusion
- age \< 18 years;
- Life expectancy \< 24 months (as estimated by the operating surgeon), -
- Pregnancy
- Immunosuppressant therapy within 2 weeks before surgery
- Clean-contaminated and contaminated, dirty wounds
- Cirrhosis
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 18 2023
Estimated Enrollment :
272 Patients enrolled
Trial Details
Trial ID
NCT06166069
Start Date
January 1 2021
End Date
November 18 2023
Last Update
December 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
francesco Pizza
Naples, Italy, 80131